Do you want to read an article? Please log in or register.
Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia
Lipids
RECOMMENDED
Related content
Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry
Atherosclerosis.
Amrock SM, Duell PB, Knickelbine T, Martin SS, O'Brien EC, Watson KE, Mitri J, Kindt I, Shrader P, Baum SJ, Hemphill LC, Ahmed CD, Andersen RL, Kullo IJ, McCann D, Larry JA, Murray MF, Fishberg R, Guyton JR, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Underberg JA, Thompson P, Duffy D, Linton MF, Shapiro MD, Moriarty PM, Knowles JW, Ahmad ZS
doi: 10.1016/
COMMENTED
Lipids
How to identify familial premature myocardial infarction: comparing approaches to identify familial hypercholesterolemia
J Clin Endocrinol Metab.
Beheshti S, Madsen CM, Varbo A, Nordestgaard BG
doi: 10.1210/jc.2018-02261.
COMMENTED
Lipids
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
★ 2
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
N Engl J Med.
Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, Kastelein JJP, Hutten BA
doi: 10.1056/NEJMoa1816454.
Child-Parent Familial Hypercholesterolemia Screening in Primary Care
N Engl J Med.
Wald DS, Bestwick JP, Morris JK, Whyte K, Jenkins L, Wald NJ
doi: 10.1056/
Lipids
Vascular inflammation and metabolic activity in hematopoietic organs and liver in familial combined hyperlipidemia and heterozygous familial hypercholesterolemia
J Clin Lipidol.
Toutouzas K, Skoumas J, Koutagiar I, Benetos G, Pianou N, Georgakopoulos A, Galanakos S, Antonopoulos A, Drakopoulou M, Oikonomou EK, Kafouris P, Athanasiadis E, Metaxas M, Spyrou G, Pallantza Z, Galiatsatos N, Aggeli C, Antoniades C, Keramida G, Peters AM, Anagnostopoulos CD, Tousoulis D
doi: 10.1016/
COMMENTED
Diabetes - GeneralLipids
Prevalence and Predictors of Cholesterol Screening, Awareness, and Statin Treatment Among US Adults With Familial Hypercholesterolemia or Other Forms of Severe Dyslipidemia (1999-2014)
Circulation.
Bucholz EM, Rodday AM, Kolor K, Khoury MJ, de Ferranti SD
doi: 10.1161/CIRCULATIONAHA.
Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia
Atherosclerosis.
Perez-Calahorra S, Laclaustra M, Marco-Benedí V, Lamiquiz-Moneo I, Pedro-Botet J, Plana N, Sanchez-Hernandez RM, Amor AJ, Almagro F, Fuentes F, Suarez-Tembra M, Civeira F; Dyslipemia Registry of Spanish Arteriosclerosis Society
doi: 10.1016/j.atherosclerosis.
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial
Eur Heart J.
Moriarty PM, Parhofer KG, Babirak SP, Cornier MA, Duell PB, Hohenstein B, Leebmann J, Ramlow W, Schettler V, Simha V, Steinhagen-Thiessen E, Thompson PD, Vogt A, von Stritzky B, Du Y, Manvelian G
doi: 10.1093/eurheartj/ehw388
Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials
Int J Cardiol.
Farnier M, Gaudet D, Valcheva V, Minini P, Miller K, Cariou B
doi: 10.1016/j.ijcard.2016.08.273.